|
Name |
L-gamma-glutamyl phosphate(2-)
|
| Molecular Formula | C5H8NO7P-2 | |
| IUPAC Name* |
(2S)-2-azaniumyl-5-oxo-5-phosphonatooxypentanoate
|
|
| SMILES |
C(CC(=O)OP(=O)([O-])[O-])[C@@H](C(=O)[O-])[NH3+]
|
|
| InChI |
InChI=1S/C5H10NO7P/c6-3(5(8)9)1-2-4(7)13-14(10,11)12/h3H,1-2,6H2,(H,8,9)(H2,10,11,12)/p-2/t3-/m0/s1
|
|
| InChIKey |
PJRXVIJAERNUIP-VKHMYHEASA-L
|
|
| Synonyms |
L-gamma-glutamyl phosphate(2-); gamma-L-glutamyl-5-P; gamma-L-glutamyl 5-phosphate; CHEBI:58274; L-gamma-glutamyl phosphate dianion; (2S)-2-ammonio-5-oxo-5-(phosphonatooxy)pentanoate; (2S)-2-azaniumyl-5-oxo-5-(phosphonatooxy)pentanoate; Q27125662
|
|
| CAS | NA | |
| PubChem CID | 44457531 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 225.09 | ALogp: | -4.3 |
| HBD: | 1 | HBA: | 7 |
| Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 157.0 | Aromatic Rings: | 0 |
| Heavy Atoms: | 14 | QED Weighted: | 0.438 |
| Caco-2 Permeability: | -6.116 | MDCK Permeability: | 0.00369561 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.081 |
| Human Intestinal Absorption (HIA): | 0.838 | 20% Bioavailability (F20%): | 0.092 |
| 30% Bioavailability (F30%): | 0.799 |
| Blood-Brain-Barrier Penetration (BBB): | 0.743 | Plasma Protein Binding (PPB): | 12.49% |
| Volume Distribution (VD): | 0.297 | Fu: | 84.35% |
| CYP1A2-inhibitor: | 0.001 | CYP1A2-substrate: | 0.018 |
| CYP2C19-inhibitor: | 0.047 | CYP2C19-substrate: | 0.033 |
| CYP2C9-inhibitor: | 0.026 | CYP2C9-substrate: | 0.689 |
| CYP2D6-inhibitor: | 0.089 | CYP2D6-substrate: | 0.11 |
| CYP3A4-inhibitor: | 0.01 | CYP3A4-substrate: | 0.004 |
| Clearance (CL): | 2.286 | Half-life (T1/2): | 0.798 |
| hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.066 |
| Drug-inuced Liver Injury (DILI): | 0.026 | AMES Toxicity: | 0.034 |
| Rat Oral Acute Toxicity: | 0.002 | Maximum Recommended Daily Dose: | 0.24 |
| Skin Sensitization: | 0.435 | Carcinogencity: | 0.023 |
| Eye Corrosion: | 0.013 | Eye Irritation: | 0.116 |
| Respiratory Toxicity: | 0.269 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001759 | ![]() |
0.409 | D0OT0O | ![]() |
0.293 | ||
| ENC002557 | ![]() |
0.296 | D03RCJ | ![]() |
0.267 | ||
| ENC001760 | ![]() |
0.239 | D01EKQ | ![]() |
0.236 | ||
| ENC000735 | ![]() |
0.234 | D04CJL | ![]() |
0.236 | ||
| ENC000234 | ![]() |
0.220 | D0QC5D | ![]() |
0.236 | ||
| ENC001900 | ![]() |
0.220 | D07QPM | ![]() |
0.228 | ||
| ENC000795 | ![]() |
0.212 | D0Q4EW | ![]() |
0.228 | ||
| ENC001253 | ![]() |
0.208 | D00ENY | ![]() |
0.224 | ||
| ENC001036 | ![]() |
0.208 | D01JIA | ![]() |
0.224 | ||
| ENC000758 | ![]() |
0.208 | D0OL6O | ![]() |
0.220 | ||